| Min Pa: | Min Pa(max): | Activity's type: |
| Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |
|---|---|---|---|---|---|---|
| 0.877 | 0.004 | 0.975 | Platelet antagonist | 0.85 0.004 DBMET01210 0.975 0.002 DBMET00098 0.943 0.003 DBMET01163 | DBMET00098 | |
| 0.829 | 0.002 | 0.899 | Platelet adhesion inhibitor | 0.803 0.002 DBMET01210 0.881 0.001 DBMET00098 0.899 0.001 DBMET01163 | DBMET01163 | |
| 0.762 | 0.004 | 0.949 | Platelet aggregation inhibitor | 0.705 0.005 DBMET01210 0.949 0.003 DBMET00098 0.9 0.003 DBMET01163 | DBMET00098 | |
| 0.631 | 0.013 | 0.817 | Antithrombotic | 0.669 0.01 DBMET01210 0.817 0.004 DBMET00098 0.456 0.036 DBMET01163 | DBMET00098 | |
| 0.487 | 0.003 | 0.487 | Purinergic P2T antagonist | 0.382 0.003 DBMET01210 0.404 0.003 DBMET00098 0.13 0.004 DBMET01163 | ||
| 0.462 | 0.039 | 0.462 | Thyroid hormone beta antagonist | 0.321 0.079 DBMET01210 0.371 0.062 DBMET01163 | ||
| 0.456 | 0.041 | 0.456 | Thyroid hormone antagonist | 0.339 0.077 DBMET01210 0.432 0.047 DBMET01163 | ||
| 0.362 | 0.01 | 0.586 | Hemostatic | 0.294 0.016 DBMET01210 0.586 0.004 DBMET00098 | DBMET00098 | |
| 0.298 | 0.018 | 0.298 | Tumour necrosis factor antagonist | 0.184 0.063 DBMET01210 | ||
| 0.234 | 0.005 | 0.234 | Purinergic P2 antagonist | 0.165 0.009 DBMET01210 0.055 0.054 DBMET00098 | ||
| 0.23 | 0.009 | 0.496 | CC chemokine receptor antagonist | 0.496 0.004 DBMET01210 0.151 0.017 DBMET00098 0.159 0.016 DBMET01163 | DBMET01210 | |
| 0.203 | 0.018 | 0.46 | Chemokine receptor antagonist | 0.46 0.005 DBMET01210 0.126 0.044 DBMET00098 0.152 0.031 DBMET01163 | DBMET01210 | |
| 0.188 | 0.005 | 0.188 | Acetylcholine release stimulant | 0.119 0.05 DBMET01210 | ||
| 0.323 | 0.143 | 0.549 | Cyclophilin D inhibitor | 0.549 0.038 DBMET01210 | DBMET01210 | |
| 0.165 | 0.003 | 0.168 | Glucose-6-phosphate translocase inhibitor | 0.168 0.003 DBMET01210 | DBMET01210 | |
| 0.165 | 0.014 | 0.165 | 5 Hydroxytryptamine uptake inhibitor | 0.071 0.038 DBMET01210 | ||
| 0.196 | 0.054 | 0.254 | Thrombolytic | 0.254 0.032 DBMET01210 0.144 0.087 DBMET01163 | DBMET01210 | |
| 0.276 | 0.135 | 0.303 | Antiobesity | 0.303 0.114 DBMET01210 0.228 0.179 DBMET00098 | DBMET01210 | |
| 0.145 | 0.01 | 0.145 | Adrenaline uptake inhibitor | 0.086 0.023 DBMET01210 | ||
| 0.115 | 0.008 | 0.115 | Purinergic P2Y antagonist | 0.11 0.008 DBMET01210 | ||
| 0.166 | 0.068 | 0.231 | Anticoagulant | 0.231 0.043 DBMET01210 | DBMET01210 | |
| 0.098 | 0.004 | 0.098 | Purinergic P2Y12 antagonist | 0.065 0.005 DBMET01210 0.056 0.006 DBMET00098 0.031 0.012 DBMET01163 | ||
| 0.138 | 0.047 | 0.145 | Papain-like protease (SARS coronavirus) inhibitor | 0.145 0.039 DBMET01210 0.134 0.053 DBMET00098 0.136 0.05 DBMET01163 | DBMET01210 | |
| 0.087 | 0.004 | 0.12 | p53 inhibitor | 0.113 0.003 DBMET01210 0.09 0.004 DBMET00098 0.12 0.003 DBMET01163 | DBMET01163 | |
| 0.11 | 0.034 | 0.11 | Alpha 2d adrenoreceptor antagonist | 0.105 0.04 DBMET01210 | ||
| 0.078 | 0.026 | 0.078 | Dopamine uptake inhibitor | |||
| 0.164 | 0.113 | 0.193 | Anticonvulsant | 0.193 0.088 DBMET01210 | DBMET01210 | |
| 0.206 | 0.159 | 0.266 | Cholesterol antagonist | 0.266 0.114 DBMET01210 | DBMET01210 | |
| 0.239 | 0.193 | 0.239 | Analgesic | |||
| 0.051 | 0.007 | 0.064 | Integrin alpha1beta1 antagonist | 0.064 0.004 DBMET01210 | DBMET01210 | |
| 0.083 | 0.044 | 0.083 | Analgesic, opioid | |||
| 0.065 | 0.033 | 0.065 | Potassium channel intermediate-conductance Ca-activated blocker | |||
| 0.135 | 0.104 | 0.135 | Heat shock protein 90 alpha antagonist | |||
| 0.048 | 0.02 | 0.058 | Nerve growth factor antagonist | 0.058 0.01 DBMET01210 | DBMET01210 | |
| 0.054 | 0.036 | 0.081 | Elastase inhibitor | 0.081 0.016 DBMET00098 | DBMET00098 | |
| 0.023 | 0.006 | 0.023 | Microsomal triglyceride transfer protein inhibitor | |||
| 0.042 | 0.026 | 0.062 | Phenylethanolamine N methyltransferase inhibitor | 0.045 0.021 DBMET01210 0.062 0.007 DBMET00098 | DBMET00098 | |
| 0.05 | 0.036 | 0.135 | CC chemokine 5 receptor antagonist | 0.135 0.005 DBMET01210 | DBMET01210 | |
| 0.076 | 0.062 | 0.147 | Histamine H1 receptor antagonist | 0.147 0.025 DBMET01210 | DBMET01210 | |
| 0.079 | 0.067 | 0.232 | NMDA receptor antagonist | 0.232 0.01 DBMET01210 | DBMET01210 | |
| 0.025 | 0.013 | 0.025 | Urotensin II antagonist | 0.021 0.017 DBMET01210 | ||
| 0.101 | 0.089 | 0.101 | Acetylcholine muscarinic antagonist | |||
| 0.095 | 0.086 | 0.105 | DOPA decarboxylase inhibitor | 0.105 0.067 DBMET01210 0.096 0.084 DBMET01163 | DBMET01210 | |
| 0.054 | 0.047 | 0.054 | Protein kinase C iota inhibitor | |||
| 0.185 | 0.184 | 0.216 | 5 Hydroxytryptamine uptake stimulant | 0.216 0.123 DBMET01210 | DBMET01210 | |
| 0.042 | 0.041 | 0.091 | GP IIb/IIIa receptor antagonist | 0.091 0.019 DBMET01210 0.049 0.033 DBMET01163 | DBMET01210 | |
| 0.05 | 0.057 | 0.075 | NMDA receptor glycine site agonist | 0.075 0.032 DBMET01210 | DBMET01210 | |
| 0.029 | 0.038 | 0.196 | Integrin antagonist | 0.196 0.007 DBMET01210 | DBMET01210 | |
| 0.155 | 0.17 | 0.188 | Hypoglycemic | 0.188 0.124 DBMET01210 | DBMET01210 | |
| 0.154 | 0.171 | 0.171 | Cardiotonic | 0.171 0.15 DBMET01210 | DBMET01210 | |
| 0.121 | 0.144 | 0.203 | DNA methyltransferase I inhibitor | 0.203 0.068 DBMET01210 | DBMET01210 | |
| 0.025 | 0.056 | 0.045 | Urate transporter 1 inhibitor | 0.045 0.022 DBMET01210 | DBMET01210 | |
| 0.058 | 0.089 | 0.088 | MDM2 inhibitor | 0.066 0.051 DBMET01210 0.088 0.013 DBMET01163 | DBMET01163 | |
| 0.118 | 0.156 | 0.204 | DNA methylase inhibitor | 0.204 0.077 DBMET01210 | DBMET01210 | |
| 0.078 | 0.122 | 0.093 | Toll-Like receptor 4 antagonist | 0.093 0.083 DBMET01163 | DBMET01163 | |
| 0.04 | 0.106 | 0.06 | NMDA receptor agonist | 0.06 0.047 DBMET01210 | DBMET01210 | |
| 0.165 | 0.252 | 0.218 | 15-Lipoxygenase inhibitor | 0.218 0.194 DBMET01210 | DBMET01210 | |
| 0.062 | 0.158 | 0.088 | Electrolyte absorption antagonist | 0.088 0.078 DBMET01210 | DBMET01210 | |
| 0.014 | 0.109 | 0.333 | Sigma receptor antagonist | 0.333 0.005 DBMET00098 | DBMET00098 | |
| 0.005 | 0.105 | 0.035 | Prostaglandin D2 antagonist | 0.035 0.009 DBMET01163 | DBMET01163 | |
| 0.025 | 0.128 | 0.049 | Carnitine palmitoyltransferase 1B inhibitor | 0.049 0.03 DBMET01163 | DBMET01163 | |
| 0.049 | 0.202 | 0.114 | Glutamate receptor antagonist | 0.114 0.08 DBMET01210 | DBMET01210 | |
| 0.014 | 0.186 | 0.052 | Prostaglandin antagonist | 0.052 0.038 DBMET01163 | DBMET01163 | |
| 0.067 | 0.249 | 0.169 | Cell wall synthesis inhibitor | 0.169 0.048 DBMET01210 | DBMET01210 | |
| 0.029 | 0.231 | 0.052 | DNA helicase inhibitor | 0.052 0.044 DBMET01163 | DBMET01163 | |
| 0.083 | 0.294 | 0.145 | Succinate dehydrogenase inhibitor | 0.141 0.131 DBMET01210 0.145 0.122 DBMET01163 | DBMET01163 | |
| 0.124 | 0.346 | 0.183 | Tyrosine 3 hydroxylase inhibitor | 0.183 0.169 DBMET01210 | DBMET01210 | |
| 0.055 | 0.295 | 0.132 | Diuretic | 0.132 0.092 DBMET01210 | DBMET01210 | |
| 0.008 | 0.381 | 0.198 | HIV-1 integrase (Strand Transfer) inhibitor | 0.198 0.009 DBMET01163 | DBMET01163 | |
| 0.014 | 0.451 | 0.074 | HIV-1 integrase inhibitor | 0.074 0.043 DBMET01163 | DBMET01163 | |
| 0.006 | 0.48 | 0.17 | HIV-1 integrase (3'-Processing) inhibitor | 0.17 0.012 DBMET01163 | DBMET01163 | |
| 0.068 | 0.679 | 0.23 | Interleukin 2 agonist | 0.23 0.143 DBMET01163 | DBMET01163 | Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |